Opiant Pharmaceuticals Story

OPNTDelisted Stock  USD 20.65  0.00  0.00%   
Slightly above 56% of Opiant Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Opiant Pharmaceuticals suggests that many traders are alarmed regarding Opiant Pharmaceuticals' prospects. Opiant Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Opiant Pharmaceuticals. The current market sentiment, together with Opiant Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Opiant Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Opiant Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Opiant daily returns and investor perception about the current price of Opiant Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Opiant Pharmaceuticals.

Opiant Pharmaceuticals Latest Timeline

Opiant Pharmaceuticals is listed for 20.65. About 42.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 6.53. Opiant Pharmaceuticals last dividend was issued on the September 10, 2012. The entity had 1:100 split on the 31st of December 2014.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Opiant Stock

If you are still planning to invest in Opiant Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Opiant Pharmaceuticals' history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities